Dienogest Visanne is effective in treating endometriosis

It is a new type of selective progesterone receptor agonist that can inhibit ovarian function and endometrial cell proliferation, thereby reducing the pain associated with endometriosis (EMs) and shrinking and shrinking the lesions. Generally speaking, it has better safety and tolerability, is suitable for long-term use, and can be used as a first-line recommended drug.

Studies have confirmed that after taking dienogest Visanne for 2 years, there is basically no recurrence; taking dienogest for 5 years, there is only a 4% cumulative recurrence rate. This drug is a progesterone specially developed for the treatment of endometriosis. It is a first-line/level A treatment option for endometriosis recommended by authoritative guidelines in various countries.

Clinical evidence shows that the analgesic effect and onset speed of dienogest Visanne are equivalent to those of GnRH-a injection. Dienogest Visanne is more advantageous in terms of safety, as it does not have the unbearable perimenopausal symptoms associated with GnRHa use.

Dienogest Visanne can effectively shrink lesions and slow down disease progression because it controls the occurrence and development of lesions through central and peripheral multiple mechanisms, so it can produce high-efficiency pain relief for endometriosis and better reduce lesions. A large number of clinical trials have shown that 24 weeks of treatment with dienogest Visanne can significantly shrink the lesions in patients with endometriosis, and the effect is definite.

The drug can relieve the pain of patients with endometriosis, improve the patient's quality of life and disease progression, have a positive effect on the patient's condition, and has a significant therapeutic effect. The launch of dienogest Visanne has brought new treatment options and options to many patients with endometriosis.

The above is an introduction to Dienogest. If patients want to know more about the latest drug information about this drug (such as the price of Dienogest, how to purchase it, precautions, etc.), they can contact the Medical Companion Travel Service at any time.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related hot articles